Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Feb 07, 2012 Support grows for medical-device community -
Dec 19, 2011 BioAccel launches network to attract bio funding
-
Jul 19, 2011 Cardinal Health opens $11M Phoenix facility
-
Apr 07, 2011 Algae Biosciences Corp. taken public
Share on Twitter
Share on Facebook
Email to a friend
Print Article
New genomic test for coronary artery disease now available at Heart & Vascular Center of Arizona
[Source: PRNewswire] - The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain. Corus CAD is a new genomic test launched in select U.S. markets, and the Heart & Vascular Center of Arizona is among the first institutions in the country to offer this first-of-its-kind gene expression test to patients with possible cardiovascular disease.
For more information: New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
Quick Links
- NEW: About the Arizona Center for Civic Leadership
- Arizona Biosciences News
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Arizona BioBasics
- The Biozona Brand
- Newsletter Signup
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.
